Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology

Figure 5

Molecular docking of active compounds and core genes: (a) TNF-quercetin, (b) CXCL8-quercetin, (c) IL-1B-quercetin, (d) IL6-quercetin, (e) MMP9-luteolin, and (f) TNF-kaempferol.

(a)

(b)

(c)

(d)

(e)

(f)